Jonathan M. Meyer, MD
a:2:{i:0;s:83:"Department of Psychiatry, University of California San Diego, San Diego, California";i:1;s:155:"
ASCP Corner
Clozapine Monitoring in the Post-REMS World: Some Guidance for Clinicians
May 5, 2025
While the abolition of REMS for clozapine expands access, the change could create confusion. Among the most relevant examples are mismatches between FDA recommendations for lifetime monitoring and the...